Partner
TEL |
+82-2-772-4903 |
E-MAIL |
hyunah.song@leeko.com |
|
|
Hyun Ah Song is a partner in the Corporate Practice Group and Healthcare/Life Science Group. Her practice focuses primarily in the areas of life science and healthcare, corporate law, M&A, corporate governance and China practice.
Ms. Song has handled various life science and healthcare matters including advice on regulatory matters related with government authorities, fair trade and anti-trust issues including ethical business practices and white collar crimes: on-site support for KFTC investigation, criminal defense in kickback cases, establishment of internal policies and SOPs, etc. In addition to this, she has advised on healthcare-related matters such as clinical trial agreements, distribution agreements (co-marketing/co-promotion), logistics and warehousing agreements, global license-in and license-out cases, market access project, data protection issues and general corporate matters including establishment of Korean branches or affiliates, M&A transactions, corporate governance, labor issues, etc.
Education
2019 |
Fordham University School of Law – LL.M. |
2012 |
Sungkyunkwan University Law School - J.D. |
2008 |
Sogang University – College of Chinese Culture and Management |
Work Experience
2012-Present |
Lee & Ko |
2022-Present |
Member of the In Vitro Diagnostic Device Expert Committee of the Ministry of the Food and Drug Safety |
2021-Present |
Member of the Medical Device Advertisements Self-Regulation Committee |
Expertise
Corporate Governance |
Life Sciences · Pharmaceuticals |
Healthcare |
China |
Mergers & Acquisitions |
Regulatory Compliance |
Admissions
Admitted to bar, Korea(2012) |
Languages
Korean, Chinese and English |
Publications / Presentations / ETC
- Pharmaceutical Advertising (Korea Chapter): International Comparative Legal Guide (2021, 2022)
- Medicinal Product Regulation and Product Liability (Korea Chapter): A Global Guide From Practical Law (2021, 2022, Thomson Reuters)
- The Healthcare Law Review (Korea Chapter) (2021)
- Life Sciences (Korea Chapter): Lexology Getting The Deal Through (2020, 2021)
- Pharma & Medical Device Regulation (Korea Chapter): Lexology Getting The Deal Through (2022)